Globus Medical Inc vs Abbvie Inc.
GMED vs ABBV — side-by-side comparison from reported financials. GMED leads 6, ABBV leads 3 of 9 comparable metrics.
Globus Medical Inc
GMED · Healthcare
$74.10+1.05%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | GMED | ABBV |
|---|---|---|
| Price | $74.10 | $276.43 |
| Market cap | $9.95B | $488B |
| Revenue (TTM) | $3.14B | $64.4B |
| Revenue growth | +42.2% | +1.8% |
| Net margin | 17.0% | 9.8% |
| Free cash flow | $756M | $18.2B |
| Net cash (debt) | — | ($56.2B) |
| 1-year price return | +24.3% | +19.8% |
| P/E | 18.7 | 77.4 |
| P/E vs own history (cheap-side %) | 98% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 12% | 96% |
| Altman Z-score | 9.56 | 2.33 |
| CV checks passed | 9 of 10 | 9 of 10 |
| Employees | 6,000 | 57,000 |
Full résumé-style profiles: GMED CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.